Menopausa e síndrome metabólica

Dydrogesterone does not reverse the cardiovascular benefits of percutaneous estradiol

(2012) V. M. Kuba et al.   CLIMACTERIC

Metabolic syndrome and the risk of breast cancer in postmenopausal women

(2011) V. Rosato et al.   ANNALS OF ONCOLOGY

Gluteofemoral body fat as a determinant of metabolic health

(2010) K N Manolopoulos et al.   INTERNATIONAL JOURNAL OF OBESITY

Sex, Menopause, Metabolic Syndrome, and All-Cause and Cause-Specific Mortality—Cohort Analysis from the Third National Health and Nutrition Examination Survey

(2010) Jou-Wei Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The relationship between visfatin and metabolic syndrome in postmenopausal women

(2010) Jung-Ha Kim et al.   MATURITAS

Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study

(2010) Ramin Heidari et al.   Diabetology & Metabolic Syndrome

A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer

(2009) G. C. Kabat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Type and route of estrogen administration

(2009) J. C. Stevenson   CLIMACTERIC

Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women

(2009) Ulysse Gaspard   MATURITAS

Menopause is an independent predictor of metabolic syndrome in Iranian women

(2009) Radina Eshtiaghi et al.   MATURITAS

Impairment of the Natriuretic Peptide System in Follitropin Receptor Knockout Mice and Reversal by Estradiol: Implications for Obesity-Associated Hypertension in Menopause

(2007) Najara O. Belo et al.   ENDOCRINOLOGY